Grifols' founding family and Brookfield discuss €5.5B joint takeover bid to acquire Spanish drugmaker Grifols, aiming for delisting.
Grifols' founding family and Canadian fund manager Brookfield are in talks for a joint takeover bid worth approximately €5.5 billion ($5.96 billion) to acquire Spanish drugmaker Grifols, with the intent to delist it. The move comes after Grifols faced a significant decline in market value due to a short-seller attack by Gotham City Research, which accused the company of manipulating debt and profit figures.
July 08, 2024
10 Articles